Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael K Racke

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Therapeutic Advances in Neurological Disorders|December 25, 2010
Challenges in developing new multiple sclerosis therapiesMichael K Racke
Journal of Neuroimmunology|March 25, 2011
Because it is our journalMichael K Racke
Annals of Indian Academy of Neurology|February 26, 2010
Immunopathogenesis of multiple sclerosisMichael K Racke
Archives of Neurology|December 15, 2010
Understanding the effects of FTY720 on leukocyte traffickingMichael K Racke
Journal of Neuroimmunology|July 26, 2016
Therapeutic developments for autoimmune demyelinating diseases: Musings from an MD (mouse doctor)Michael K Racke
Current Opinion in Neurology|June 17, 2008
The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapiesMichael K Racke
Nature Reviews. Neurology|September 19, 2012
Disease mechanisms in MS: the potassium channel KIR4.1--a potential autoantigen in MSMichael K Racke
JAMA Neurology|December 23, 2014
Is no evidence of disease activity a realistic goal for patients with multiple sclerosis?Jaime Imitola, Michael K Racke
JAMA Neurology|June 14, 2016
Cortical Volume Loss and Neurologic Dysfunction in Multiple SclerosisMichael K Racke, Jaime Imitola
JAMA Neurology|February 28, 2017
Selection of Patients With Multiple Sclerosis to Undergo Autologous Hematopoietic Stem Cell TransplantationMichael K Racke, Jaime Imitola
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Therapeutic Advances in Neurological Disorders|December 25, 2010
Challenges in developing new multiple sclerosis therapiesMichael K Racke
Journal of Neuroimmunology|March 25, 2011
Because it is our journalMichael K Racke
Annals of Indian Academy of Neurology|February 26, 2010
Immunopathogenesis of multiple sclerosisMichael K Racke
Archives of Neurology|December 15, 2010
Understanding the effects of FTY720 on leukocyte traffickingMichael K Racke
Journal of Neuroimmunology|July 26, 2016
Therapeutic developments for autoimmune demyelinating diseases: Musings from an MD (mouse doctor)Michael K Racke
Current Opinion in Neurology|June 17, 2008
The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapiesMichael K Racke
Nature Reviews. Neurology|September 19, 2012
Disease mechanisms in MS: the potassium channel KIR4.1--a potential autoantigen in MSMichael K Racke
JAMA Neurology|December 23, 2014
Is no evidence of disease activity a realistic goal for patients with multiple sclerosis?Jaime Imitola, Michael K Racke
JAMA Neurology|June 14, 2016
Cortical Volume Loss and Neurologic Dysfunction in Multiple SclerosisMichael K Racke, Jaime Imitola
JAMA Neurology|February 28, 2017
Selection of Patients With Multiple Sclerosis to Undergo Autologous Hematopoietic Stem Cell TransplantationMichael K Racke, Jaime Imitola
Pageof 15